- About
- PsychU For You
- Topics
- Events
- Content
Addressing Caregiver Burden & Identifying Agitation in Alzheimer’s Dementia
Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:
About This Event
Addressing Caregiver Burden & Identifying Agitation in Alzheimer’s Dementia
Over 11 million Americans provide unpaid care for people with Alzheimer’s or other dementia.1 The majority (80%) of people with Alzheimer’s disease and related dementia are receiving care in their home.2 The demand for caregivers and the burden can negatively impact their quality of life and ability to provide care. Come and join us for this webinar, as our speaker and moderator highlight the impact of caregiver burden, discuss challenges in recognizing agitation in Alzheimer’s dementia, and share tools that caregivers can utilize in identifying and managing this condition. References:
- Alzheimer’s Association. Facts and figures infographic. alzheimers-facts-and-figures-infographic.pdf. Accessed: September 2024.
- Center for Disease Control and Prevention (CDC). Caregiving for a Person with Alzheimer’s Disease or a Related Dementia. Caregiving for Person with Alzheimer’s Disease or a related Dementia | Alzheimer’s Disease and Healthy Aging | CDC. Accessed: September 2024
E. Jeffrey Greenberg, MD
Neurologist at Princeton & Rutgers Neurology, P.A., Co-Founder of Advanced Clinical Institute
MoreDr. Jeffrey Greenberg, a native of Philadelphia, joined Princeton & Rutgers Neurology in 2003. He received his Bachelor’s degree in English from Cornell University and his medical degree from Drexel University, College of Medicine. He completed his Neurology residency at the Albert Einstein College of Medicine in New York, serving as Chief Resident in his final year. He subsequently completed an EMG/Neuromuscular fellowship at Albert Einstein. He is Board Certified in Neurology by the American Board of Psychiatry and Neurology and also Board Certified by the American Associate of Neuromuscular and Electrodiagnostic Medicine. Dr. Greenberg now focuses his practice on Parkinson’s Disease, Dementia, Multiple Sclerosis, and Neuromuscular Disease. Additionally, he has experience as a Principle Investigator for Alzheimer’s disease clinical trials and remains involved in the field.
Lindsey Wright, PharmD (OPDC)
Medical Science Liaison
E. Jeffrey Greenberg, MD is a paid consultant of Otsuka Pharmaceutical Development & Commercialization, Inc.
Lindsey Wright, PharmD is a paid employee of Otsuka Pharmaceutical Development & Commercialization, Inc.
Disclaimer: PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and Lundbeck, LLC – committed supporters of the mental health treatment community. The opinions expressed by PsychU’s contributors are their own and are not endorsed or recommended by PsychU or its sponsors. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU’s educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC, OAPI, and / or Lundbeck, LLC.
September 2024 US.CORP.X.24.00271Registration
- PsychU For You
